The Future of Pharma Data, AI, and Drug Development - with Glen de Vries of Medidata
Glen de Vries cofounded Medidata in 1999, offering SaaS-based clinical development solutions addressing the functioning of customers' clinical trials, and 20 years later the company - which he still leads - sold to Dassault Systemes for almost $6 billion. What a triumph, Glen! Thank you for joining the podcast. Listen in as Glen shares his unique and valuable perspective on the current state and potential futures for the data ecosystem in Life Sciences. Want to stay on the cutting edge of emerging data-driven technologies? Try out Emerj Plus: emerj.com/p1